Electrophysiological phenotypes of suicidality predict prolonged response to oral ketamine treatment
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Electrophysiological phenotypes of suicidality predict prolonged response to oral ketamine treatment
Authors
Keywords
-
Journal
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
Volume 123, Issue -, Pages 110701
Publisher
Elsevier BV
Online
2022-12-22
DOI
10.1016/j.pnpbp.2022.110701
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Low dose oral ketamine treatment in chronic suicidality: An open-label pilot study
- (2021) Adem T. Can et al. Translational Psychiatry
- Auditory evoked potentials and suicidal behaviors in patients with major depressive disorders
- (2021) Ji Sun Kim et al. Scientific Reports
- Electrophysiological biomarkers of antidepressant response to ketamine in treatment-resistant depression: Gamma power and long-term potentiation
- (2020) Jessica R. Gilbert et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Discontinuation of antidepressants after remission with antidepressant medication in major depressive disorder: a systematic review and meta-analysis
- (2020) Masaki Kato et al. MOLECULAR PSYCHIATRY
- Using Bayes factor hypothesis testing in neuroscience to establish evidence of absence
- (2020) Christian Keysers et al. NATURE NEUROSCIENCE
- Gray matter volume of rostral anterior cingulate cortex predicts rapid antidepressant response to ketamine
- (2020) Ana Herrera-Melendez et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Using classification and regression tree modelling to investigate treatment response to a single low-dose ketamine infusion: Post hoc pooled analyses of randomized placebo-controlled and open-label trials
- (2020) Mu-Hong Chen et al. JOURNAL OF AFFECTIVE DISORDERS
- Early symptomatic improvements as a predictor of response to repeated-dose intravenous ketamine: Results from the Canadian Rapid Treatment Center of Excellence
- (2020) Orly Lipsitz et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites
- (2019) Chun Yang et al. Translational Psychiatry
- Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
- (2018) Panos Zanos et al. PHARMACOLOGICAL REVIEWS
- Identifying Ketamine Responses in Treatment-Resistant Depression Using a Wearable Forehead EEG
- (2018) Zehong Cao et al. IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
- Clinical predictors of antidepressant response to ketamine in unipolar treatment-resistant depression
- (2017) L.C. Del Sant et al. EUROPEAN PSYCHIATRY
- Role of 5-HT1A Receptor Stimulation in the Medial Prefrontal Cortex in the Sustained Antidepressant Effects of Ketamine
- (2017) Kenichi Fukumoto et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- The antidepressant efficacy of subanesthetic-dose ketamine does not correlate with baseline subcortical volumes in a replication sample with major depressive disorder
- (2017) Mark J Niciu et al. JOURNAL OF PSYCHOPHARMACOLOGY
- A Quantitative Electrophysiological Biomarker of Duplication 15q11.2-q13.1 Syndrome
- (2016) Joel Frohlich et al. PLoS One
- Ketamine and Rapid-Acting Antidepressants: A Window into a New Neurobiology for Mood Disorder Therapeutics
- (2015) Chadi G. Abdallah et al. Annual Review of Medicine
- Review on EEG and ERP predictive biomarkers for major depressive disorder
- (2015) Wajid Mumtaz et al. Biomedical Signal Processing and Control
- Improvement in suicidal ideation after ketamine infusion: Relationship to reductions in depression and anxiety
- (2014) Elizabeth D. Ballard et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Hippocampal volume and the rapid antidepressant effect of ketamine
- (2014) Chadi G Abdallah et al. JOURNAL OF PSYCHOPHARMACOLOGY
- MEG and EEG data analysis with MNE-Python
- (2014) Alexandre Gramfort Frontiers in Neuroscience
- Subanesthetic Doses of Ketamine Transiently Decrease Serotonin Transporter Activity: A PET Study in Conscious Monkeys
- (2013) Shigeyuki Yamamoto et al. NEUROPSYCHOPHARMACOLOGY
- Baseline delta sleep ratio predicts acute ketamine mood response in major depressive disorder
- (2012) Wallace C. Duncan et al. JOURNAL OF AFFECTIVE DISORDERS
- The neurobiology of the EEG biomarker as a predictor of treatment response in depression
- (2012) Anusha Baskaran et al. NEUROPHARMACOLOGY
- NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
- (2011) Anita E. Autry et al. NATURE
- Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder
- (2010) Nancy DiazGranados et al. JOURNAL OF CLINICAL PSYCHIATRY
- Loudness dependence of auditory evoked potentials (LDAEP) correlates with the availability of dopamine transporters and serotonin transporters in healthy volunteers—a two isotopes SPECT study
- (2010) I Hui Lee et al. PSYCHOPHARMACOLOGY
- Effects of Intravenous Ketamine on Explicit and Implicit Measures of Suicidality in Treatment-Resistant Depression
- (2009) Rebecca B. Price et al. BIOLOGICAL PSYCHIATRY
- Loudness Dependence of Auditory Evoked Potentials as Indicator of Central Serotonergic Neurotransmission: Simultaneous Electrophysiological Recordings and In Vivo Microdialysis in the Rat Primary Auditory Cortex
- (2008) Alexander Wutzler et al. NEUROPSYCHOPHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started